Abstract
Aim: Obesity is known to be associated with many diseases in the long and short terms. Elevated oxidative stress contributes to the development of such obesity-related diseases as dyslipidemia, diabetes mellitus and hypertension. Levels of the endogenous antioxidants paraoxonase and arylesterase have been shown to decrease in such diseases. The purpose of this study was to investigate whether or not changes in lifestyle and metformin therapy would affect serum paraoxonase and arylesterase levels.
Materials and methods: The study was performed with 25 overweight, 26 obese and 25 morbidly obese patients aged 6–15 years as well as 27 healthy children. Serum paraoxonase (PON1) and arylesterase (ARE) activity levels and total cholesterol, triglyceride, low-density protein, high-density protein, very low-density protein, glucose, aspartate amino transferase and alanine amino transferase levels were measured. Enrolled patients were assessed at initial presentation and again at 6 months. No procedure was performed in the control group, while the overweight, obese and morbidly obese groups were recommended diet and exercise and given metformin therapy (insulin-resistant subjects only).
Results: Serum PON1 activity levels in patients with metabolic syndrome were significantly lower than those in individuals without metabolic syndrome (p<0.05), while lipid concentrations were significantly higher (p<0.05). Metabolic syndrome patients had higher serum glucose, total cholesterol, low-density protein, very low-density protein and triglyceride values compared to those of the control group but significantly lower high-density protein values (p<0.05). No difference was determined between the groups in terms of PON1 and ARE levels following diet and exercise and metformin therapy.
Conclusion: Measurement of PON1 and ARE enzyme levels may be useful in monitoring the effectiveness of treatment aimed at reducing oxidative stress in obese children.
References
1. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003–2006. J Am Med Assoc 2008;299:2401–5.10.1001/jama.299.20.2401Search in Google Scholar PubMed
2. Crocker MK, Yanovski JA. Pediatric obesity: etiology and treatment. Pediatr Clin North Am 2011;58:1217–40.10.1016/j.pcl.2011.07.004Search in Google Scholar PubMed PubMed Central
3. Alfadda AA, Sallam RM. Reactive oxygen species in health and disease. J Biomed Biotechnol 2012;2012:936486.Search in Google Scholar
4. Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 2011;106(Suppl 3):S5–78.10.1017/S0007114511005460Search in Google Scholar PubMed
5. Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009;47:372–81.10.1016/j.yjmcc.2009.05.013Search in Google Scholar PubMed
6. Daniels SR, Arnett DK, Eckel RH, Gidding SS, Hayman LL, et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 2005;111:1999–2012.10.1161/01.CIR.0000161369.71722.10Search in Google Scholar PubMed
7. De Marchi E, Baldassari F, Bononi A, Wieckowski MR, Pinton P. Oxidative stress in cardiovascular diseases and obesity: role of p66Shc and protein kinase C. Oxid Med Cell Longev 2013;2013:564961.10.1155/2013/564961Search in Google Scholar PubMed PubMed Central
8. Murdolo G, Piroddi M, Luchetti F, Tortoioli C, Canonico B, et al. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance. Biochimie 2013;95:585–94.10.1016/j.biochi.2012.12.014Search in Google Scholar PubMed
9. Tran B, Oliver S, Rosa J, Galassetti P. Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: an overview of ten years of studies. Exp Diabetes Res 2012;2012:683680.10.1155/2012/683680Search in Google Scholar PubMed PubMed Central
10. de Heredia FP, Gomez-Martinez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc 2012;71:332–8.10.1017/S0029665112000092Search in Google Scholar PubMed
11. Higdon JV, Frei B. Obesity and oxidative stress: a direct link to CVD? Arterioscler Thromb Vasc Biol 2003;23:365–7.10.1161/01.ATV.0000063608.43095.E2Search in Google Scholar PubMed
12. Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, et al. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 2001;21:542–7.10.1161/01.ATV.21.4.542Search in Google Scholar
13. La Du BN, Aviram M, Billecke S, Navab M, Primo-Parmo S, et al. On the physiological role(s) of the paraoxonases. Chem Biol Interact 1999;119–20:379–88.10.1016/S0009-2797(99)00049-6Search in Google Scholar
14. Malkoç I, Mazıcıoğlu MM, Özkan B, Kondolot M, Kurtoğlu S, et al. Height, weight and body mass index percentiles of children aged 6-14 years living at moderate altitudes. J Clin Res Pediatr Endocrinol 2012;4:14–20.10.4274/jcrpe.559Search in Google Scholar
15. Hatipoğlu N, Kurtoğlu S, Oztürk A, Mazıcıoğlu MM. The weight and height percentiles in 6–18 year old children in Kayseri and comparison with Istanbul data. J Clin Res Pediatr Endocrinol 2009;1:129–35.10.4008/jcrpe.v1i3.47Search in Google Scholar
16. Kiess W, Galler A, Reich A, Müller G, Kapellen T, et al. Clinical aspects of obesity in childhood and adolescence. Obes Rev 2001;2:29–36.10.1046/j.1467-789x.2001.00017.xSearch in Google Scholar
17. Ross MM, Kolbash S, Cohen GM, Skelton JA. Multidisciplinary treatment of pediatric obesity: nutrition evaluation and management. Nutr Clin Pract 2010;25:327–34.10.1177/0884533610373771Search in Google Scholar
18. Spear BA, Barlow SE, Ervin C, Ludwig DS, Saelens BE, et al. Recommendations for treatment of child and adolescent overweight and obesity. Pediatrics 2007;120(Suppl 4):S254–88.10.1542/peds.2007-2329FSearch in Google Scholar
19. Guideline for Diabetes in Childhood and Adolescence. In: IDF/ISPAD G, ed, 2011. Available at: http://www.idf.org/sites/default/files/Diabetes-in-Childhood-and-Adolescence-Guidelines.pdf.Search in Google Scholar
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.10.1007/BF00280883Search in Google Scholar
21. Lifshitz F. Obesity in children. J Clin Res Pediatr Endocrinol 2008;1:53–60.10.4008/jcrpe.v1i2.35Search in Google Scholar
22. Sothern MS. Exercise as a modality in the treatment of childhood obesity. Pediatr Clin North Am 2001;48:995–1015.10.1016/S0031-3955(05)70353-9Search in Google Scholar
23. Laurson KR, Eisenmann JC, Welk GJ, Wickel EE, Gentile DA, et al. Combined influence of physical activity and screen time recommendations on childhood overweight. J Pediatr 2008;153: 209–14.10.1016/j.jpeds.2008.02.042Search in Google Scholar
24. Aronne LJ, Nelinson DS, Lillo JL. Obesity as a disease state: a new paradigm for diagnosis and treatment. Clin Cornerstone 2009;9:9–25;discussion 26–9.10.1016/S1098-3597(09)80002-1Search in Google Scholar
25. Gupta N, Goel K, Shah P, Misra A. Childhood obesity in developing countries: epidemiology, determinants, and prevention. Endocr Rev 2012;33:48–70.10.1210/er.2010-0028Search in Google Scholar PubMed
26. Zhou P, Chaudhari RS, Antal Z. Gender differences in cardiovascular risks of obese adolescents in the Bronx. J Clin Res Pediatr Endocrinol 2010;2:67–71.10.4274/jcrpe.v2i2.67Search in Google Scholar PubMed PubMed Central
27. Tascilar ME, Yokusoglu M, Boyraz M, Baysan O, Köz C, et al. Cardiac autonomic functions in obese children. J Clin Res Pediatr Endocrinol 2011;3:60–4.Search in Google Scholar
28. Boyd GS, Koenigsberg J, Falkner B, Gidding S, Hassink S. Effect of obesity and high blood pressure on plasma lipid levels in children and adolescents. Pediatrics 2005;116:442–6.10.1542/peds.2004-1877Search in Google Scholar PubMed
29. Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006;55:113–8.10.1016/j.metabol.2005.07.016Search in Google Scholar PubMed
30. Tascilar ME, Ozgen T, Cihan M, Abacı A, Yeşilkaya E, et al. The effect of insulin resistance and obesity on low-density lipoprotein particle size in children. J Clin Res Pediatr Endocrinol 2010;2:63–6.10.4274/jcrpe.v2i2.63Search in Google Scholar PubMed PubMed Central
31. Maritim AC, Sanders RA, Watkins JB, 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24–38.10.1002/jbt.10058Search in Google Scholar PubMed
32. Zatalia SR, Sanusi H. The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta Med Indones 2013;45:141–7.Search in Google Scholar
33. Selvaraju V, Joshi M, Suresh S, Sanchez JA, Maulik N, et al. Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease – an overview. Toxicol Mech Methods 2012;22:330–5.10.3109/15376516.2012.666648Search in Google Scholar PubMed
34. Abseyi N, Siklar Z, Berberoglu M, Hacıhamdioğlu B, Savaş Erdeve Ş, et al. Relationships between osteocalcin, glucose metabolism, and adiponectin in obese children: Is there crosstalk between bone tissue and glucose metabolism? J Clin Res Pediatr Endocrinol 2012;4:182–8.10.4274/Jcrpe.831Search in Google Scholar PubMed PubMed Central
35. Pirgon O, Bilgin H, Cekmez F, Kurku H, Dündar BN. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol 2013;5:33–9.10.4274/Jcrpe.825Search in Google Scholar
36. Wegner M, Piorunska-Stolzmann M, Araszkiewicz A, Zozulińska-Ziółkiewicz D, Wierusz-Wysocka B. Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes. Pol Arch Med Wewn 2011;121:448–54.10.20452/pamw.1113Search in Google Scholar
37. Tang WH, Hartiala J, Fan Y, Wu Y, Stewart AF, et al. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol 2012;32:2803–12.10.1161/ATVBAHA.112.253930Search in Google Scholar
38. van Himbergen TM, Roest M, de Graaf J, Jansen EH, Hattori H, et al. Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia. J Lipid Res 2005;46:445–51.10.1194/jlr.M400052-JLR200Search in Google Scholar
39. Rael LT, Bar-Or R, Aumann RM, Slone DS, Mains CW, et al. Oxidation-reduction potential and paraoxonase-arylesterase activity in trauma patients. Biochem Biophys Res Commun 2007;361:561–5.10.1016/j.bbrc.2007.07.078Search in Google Scholar
40. Novak F, Vavrova L, Kodydkova J, Novak F Sr, Hynkova M, et al. Decreased paraoxonase activity in critically ill patients with sepsis. Clin Exp Med 2010;10:21–5.10.1007/s10238-009-0059-8Search in Google Scholar
41. Krzystek-Korpacka M, Patryn E, Hotowy K, Czapińska E, Majda J, et al. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress. Adv Clin Exp Med 2013;22:229–36.Search in Google Scholar
42. Ruperez AI, Lopez-Guarnido O, Gil F, Olza J, Gil-Campos M, et al. Paraoxonase 1 activities and genetic variation in childhood obesity. Br J Nutr 2013;110:1639–47.10.1017/S0007114513001967Search in Google Scholar
43. Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T, et al. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med 2008;46:499–505.10.1515/CCLM.2008.096Search in Google Scholar
44. Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993;104:129–35.10.1016/0021-9150(93)90183-USearch in Google Scholar
45. Garin MC, Kalix B, Morabia A, James RW. Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome. J Clin Endocrinol Metab 2005;90: 2264–9.10.1210/jc.2004-1295Search in Google Scholar PubMed
©2015 by De Gruyter